Sumitomo Mitsui Trust Group and Nikko Asset Management Report 5.4% Ownership in 10x Genomics

SEC Filing SCHEDULE 13G (0001214659-25-011169)

Sumitomo Mitsui Trust Group, Inc. and Nikko Asset Management Co., Ltd. have filed a Schedule 13G with the SEC, reporting a 5.4% ownership in 10x Genomics, Inc. The filing indicates that the securities are held through their subsidiaries, Nikko Asset Management Americas, Inc. and Sumitomo Mitsui Trust Asset Management Co., Ltd. Both companies are classified as parent holding companies and non-U.S. institutions. The total number of shares beneficially owned is 6,013,989 for Sumitomo Mitsui Trust Group and 6,009,653 for Nikko Asset Management. The filing certifies that the shares were acquired in the ordinary course of business and not for the purpose of influencing the control of the issuer.